Clinical Trials Browser

Phase 2 × INDUSTRY × fluoromisonidazole × Clear all

NCT00544674 2012-12-10

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Phase 2 Terminated

5 enrolled 7 charts

Lung Neoplasms, Small Cell Lung Carcinoma